The global photodynamic therapy market size was valued at USD 4.3 billion in 2023 and is expected to hit around USD 8.42 billion by 2033, rising at a CAGR of 7% from 2024 to 2033.
Key Takeaways
- North America dominated the photodynamic therapy market with the largest share of 31% in 2023.
- By product type, the photosensitizers drugs segment held the largest share of the market in 2023.
- By light source, the lasers segment dominated the market in 2023.
- By application, the cancer segment has the largest share in the photodynamic therapy market in 2023.
- By end-user, the hospitals segment dominated the market in 2023.
Introduction:
Photodynamic therapy (PDT) is a minimally invasive medical treatment that utilizes light and a photosensitizing chemical substance to treat various medical conditions, including cancer, skin diseases, and ophthalmological disorders. PDT involves the administration of a photosensitizer drug, which accumulates in target tissues, followed by exposure to specific light wavelengths, leading to the generation of reactive oxygen species and subsequent destruction of diseased cells. This therapy offers several advantages over traditional treatment modalities, such as reduced side effects, improved tissue selectivity, and enhanced cosmetic outcomes.
Get a Sample: https://www.precedenceresearch.com/sample/3737
Growth Factors:
The photodynamic therapy market is experiencing significant growth due to several factors. Firstly, advancements in photosensitizer drugs and light delivery technologies have enhanced the efficacy and safety of PDT procedures, widening its applicability across various medical specialties. Additionally, the rising incidence of cancer and skin disorders, coupled with the growing demand for minimally invasive treatment options, is driving the adoption of PDT globally. Furthermore, increasing research and development activities aimed at expanding the therapeutic indications of PDT are expected to fuel market growth in the coming years.
Photodynamic Therapy Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 7% |
| Global Market Size in 2023 | USD 4.3 Billion |
| Global Market Size by 2033 | USD 8.42 Billion |
| U.S. Market Size in 2023 | USD 1.33 Billion |
| U.S. Market Size by 2033 | USD 2.66 Billion |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product Type, By Light Source, By Application, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
By Product Type:
- Photodynamic Therapy (PDT) Devices: These devices are used to administer photodynamic therapy, typically consisting of a light source and a photosensitizing agent.
- Photosensitizing Agents: These are drugs or compounds that are applied or injected into the body and become activated when exposed to light of a specific wavelength, leading to the destruction of targeted cells or tissues.
By Light Source:
- Laser Light Sources: Laser technology is commonly used in photodynamic therapy due to its ability to produce precise wavelengths of light necessary for activating photosensitizing agents.
- Light-Emitting Diodes (LEDs): LEDs are also used as light sources in photodynamic therapy devices, offering versatility and cost-effectiveness compared to lasers.
By Application:
- Cancer Treatment: Photodynamic therapy is used as a treatment option for various types of cancer, including skin cancer, lung cancer, esophageal cancer, and certain types of head and neck cancers.
- Dermatology: PDT is utilized in dermatology for treating various skin conditions such as acne, psoriasis, actinic keratosis, and certain types of skin cancers.
- Ophthalmology: Photodynamic therapy is employed in ophthalmology to treat conditions like age-related macular degeneration (AMD) and certain types of eye tumors.
- Other Medical Applications: PDT may also be used in the treatment of conditions like Barrett’s esophagus, periodontal disease, and certain infections.
By End User
- Hospitals & Clinics: These institutions are major users of photodynamic therapy devices for treating various medical conditions, including cancer and dermatological disorders.
- Ambulatory Surgical Centers: These centers may also utilize photodynamic therapy devices for outpatient procedures, offering convenience and cost-effectiveness.
- Research Institutes & Academic Centers: These institutions may use photodynamic therapy for research purposes, exploring its potential applications and refining treatment techniques.
Region Snapshot
The photodynamic therapy market exhibits a diversified geographical presence, with North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa being the key regions. North America dominates the market owing to the presence of well-established healthcare infrastructure, high adoption rates of innovative medical technologies, and favorable reimbursement policies. Europe follows closely, driven by increasing research initiatives and rising awareness about the benefits of PDT among healthcare professionals and patients. The Asia Pacific region is anticipated to witness rapid growth attributed to expanding healthcare expenditure, improving access to advanced medical treatments, and a growing prevalence of chronic diseases.
Read Also: U.S. Blood Pressure Monitoring Devices Market Size, Growth Report 2033
Recent Developments
- In September 2022, Quest PharmaTech Inc. declared that the Photodynamic Therapy technology license would be terminated and returned, as well as the sale of its ownership stake in Bioceltran Co., Ltd. for $300,000. A private company established in Korea called Bioceltran is creating active molecules that penetrate the skin for use in cosmetic and medicinal applications.
Competitive Landscape:
The photodynamic therapy market is characterized by intense competition among key players striving to gain a competitive edge through strategies such as product innovation, strategic collaborations, and mergers and acquisitions. Leading companies operating in the market include but are not limited to Biofrontera AG, Theralase Technologies Inc., Galderma SA, Quest PharmaTech Inc., and Biolitec AG. These players focus on developing novel photosensitizer drugs, expanding their product portfolios, and strengthening their distribution networks to capitalize on emerging opportunities in the global photodynamic therapy market. Additionally, the presence of numerous small and medium-sized enterprises adds to the competitive dynamics of the market, fostering innovation and driving market growth.
Photodynamic Therapy Market Companies
- Gladerma S.A.
- Sun Pharmaceutical Industries Ltd.
- Biofrontera
- Novartis AG
- Valeant Pharmaceuticals International, Inc.
- Quest Pharmatech, Inc.
- Hologic, Inc.
- Lumibird (Quantel Medical)
- Theralase Technologies Inc.
- Photocure ASA
- Biolitec AG
- IPG Photonics Corporation
Segments Covered in the Report
By Product Type
- Photosensitizer Drugs
- Photodynamic Therapy Devices
By Light Source
- Lasers
- Light Emitting Diodes (LEDs)
- Lamps
- Others
By Application
- Cancer
- Actinic Keratosis (AK)
- Psoriasis
- Acne
- Others
By End User
- Hospitals
- Cancer Treatment Centers
- Cosmetic and Dermatology Clinics
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
